Timothy P. Walbert - Jun 3, 2022 Form 4 Insider Report for Horizon Therapeutics Public Ltd Co (HZNP)

Role
Chairman, President and CEO, Director
Signature
/s/ Miles W. McHugh, Attorney-in-Fact
Stock symbol
HZNP
Transactions as of
Jun 3, 2022
Transactions value $
-$1,754,968
Form type
4
Date filed
6/3/2022, 07:04 PM
Previous filing
Jun 2, 2022
Next filing
Oct 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HZNP Ordinary Shares Options Exercise $554K +25K +5.74% $22.14 461K Jun 3, 2022 Direct F1
transaction HZNP Ordinary Shares Sale -$1.4M -15.2K -3.3% $92.08 446K Jun 3, 2022 Direct F2, F3
transaction HZNP Ordinary Shares Sale -$909K -9.8K -2.2% $92.74 436K Jun 3, 2022 Direct F2, F4
holding HZNP Ordinary Shares 108K Jun 3, 2022 See footnote F5
holding HZNP Ordinary Shares 100K Jun 3, 2022 See footnote F6
holding HZNP Ordinary Shares 41.2K Jun 3, 2022 By spouse F7

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HZNP Stock Option (Right to Buy) Options Exercise $0 -25K -3.26% $0.00 743K Jun 3, 2022 Ordinary Shares 25K $22.14 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 277 ordinary shares of the Issuer acquired by the reporting person on June 1, 2022 pursuant to an employee stock purchase program.
F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 1, 2021.
F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.46 to $92.45 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.47 to $93.27 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 The shares are held by the Timothy P. Walbert 2021 Gift Trust, of which the Reporting Person's spouse is the Trustee and beneficiary.
F6 The shares are held by the Keli B. Walbert 2021 Gift Trust, of which the Reporting Person is the Trustee. The beneficiaries of the Trust include the Reporting Person and his descendants.
F7 Includes 277 ordinary shares of the Issuer acquired June 1, 2022 pursuant to an employee stock purchase program.
F8 The stock option is fully vested and exercisable.